VICTOR RIVERA to Angiogenesis Inhibitors
This is a "connection" page, showing publications VICTOR RIVERA has written about Angiogenesis Inhibitors.
Connection Strength
0.019
-
Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine. J Clin Oncol. 2010 Oct 20; 28(30):4554-61.
Score: 0.019
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.